Dr. Michael M. Millenson, MD

  • Summit, NJ
  • Medical oncologist
NPI1871514224
Medicare services, 2024
294
Medicare patients, 2024
173
Part D claims, 2024
263
Publications
3
Clinical trials
1
Practice address
99 Beauvoir Avenue, Summit, NJ 07901
Practice phone
Call (908) 522-2000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Overlook Medical Center

Hospital · Summit, New Jersey

See all 4 affiliations

Find Dr. Millenson's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael M. Millenson is a medical oncologist in Summit, New Jersey

Dr. Millenson practices at Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System.

Dr. Millenson's NPI, 1871514224, was assigned on July 21, 2006. Dr. Millenson graduated from Lewis Katz School of Medicine in 1984. Dr. Millenson holds Pennsylvania license MD034861E.

NPI and contact details
NPI enumeration date
July 21, 2006
NPI status
Active
Practice phone
(908) 522-2000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
68
Medical school graduation
1984

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Michael M. Millenson practices at Overlook Medical Center in Summit, New Jersey

Dr. Millenson's primary practice is Overlook Medical Center, at 99 Beauvoir Avenue, Summit, NJ 07901 in Union County. The practice phone is (908) 522-2000.

Source: Dmand AI Affiliation Data

Dr. Michael M. Millenson is affiliated with 2 sites of care and 2 medical groups

Dr. Millenson's primary practice is Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System. Dr. Millenson is also affiliated with Fox Chase Cancer Center. The medical group on file is Abington Pulmonary & Critical Care Associates. Dmand AI also links Dr. Millenson to 1 more medical group, named with a free account.

See all 4 affiliations for Dr. Millenson

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Michael M. Millenson's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Millenson practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Overlook Medical CenterAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Millenson practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Atlantic Health System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael M. Millenson is one of 115 medical oncologists in New Jersey

Medical oncology is Dr. Millenson's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Millenson is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Millenson's licenses on file in 4 states: Pennsylvania, Maine, New Jersey and North Carolina.

Specialties and state licenses

  • Medical oncology, PennsylvaniaPrimaryLicense MD034861E · 1985 to 2026 · taxonomy 207RX0202X
  • Maine licenseSince 1988
  • New Jersey license1988 to 1991
  • North Carolina license1987 to 1988

Clinical focus

Dmand AI lists chronic leukemia, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Millenson treats.

Medical oncologists near Dr. Millenson

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael M. Millenson billed Medicare for 294 services in 2024

CMS data shows 294 Medicare services from Dr. Millenson across 4 procedure codes in 2024, for 173 Medicare patients. Medicare paid $15,312 for them. Every service was in an office.

Medicare services, 2024294
Medicare patients173
Paid by Medicare$15,312
Procedure codes4

Dr. Millenson's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5752024: 23459%
Other services
2023: 02024: 60

Dr. Millenson compared with the New Jersey median for medical oncologists, 2024

  • Dr. Millenson
  • New Jersey median
Medicare services
294vs 72359% below
Medicare patients
173vs 23225% below
Part D claims
173vs 35952% below

Medians across 107 medical oncologists in New Jersey with Dmand AI profiles that report each measure.

Dr. Millenson's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Millenson

Need commercial claims for Dr. Millenson?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Millenson and other medical oncologists in New Jersey.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Michael M. Millenson treated 173 Medicare patients in 2024, average age 76

CMS counts 173 Medicare patients who saw Dr. Millenson in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Millenson's median patient age at 73, with 65% women.

Medicare patients, 2024173
Average age76
Average risk score2.11
Also on Medicaid6%

Dr. Millenson's Medicare patients by age, 2024

Dr. Millenson's Medicare patients by sex, 2024

  • Women8750%
  • Men8650%

Chronic conditions among Dr. Millenson's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis56%
  4. Chronic kidney disease40%
  5. Ischemic heart disease33%
  6. Atrial fibrillation29%
  7. Diabetes28%
  8. Mood disorders28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Millenson's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women65%
  • Men29%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Michael M. Millenson wrote 263 Medicare Part D claims in 2024

In 2024, Dr. Millenson wrote 263 Medicare Part D claims for 57 patients. 61% of them were for generic drugs. CMS names the drug for 173 of them, across 8 drugs with 11 or more claims each, at $671,134 in total drug cost. In 2023, CMS named 403 claims across 15 drugs.

Part D claims, 2024263
Drugs named by CMS8
Total drug cost$671,134
Part D patients57

Dr. Millenson's Part D claims by kind of drug, 2024

  • Generic160 claims61%
  • Brand-name103 claims39%

Dr. Millenson's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4032024: 17357%

Drugs named by CMS: 8 in 2024, 15 in 2023.

See all prescribing by Dr. Millenson

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find medical oncologists like Dr. Millenson by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael M. Millenson has 3 publications on record

Dmand AI links 3 papers to Dr. Millenson, published from 2014 to 2018. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell. Dr. Millenson's most frequent co-authors are Sikander Ailawadhi, MD, Stephen M. Ansell, MD and Siddhartha Ganguly, MD.

Papers3
Years published2014 to 2018

Dr. Millenson's papers by year, 2014 to 2018

Topics Dr. Millenson writes about most

  • Leukemia, Lymphocytic, Chronic, B-Cell

Dr. Millenson's most frequent co-authors

Recent publications by Dr. Millenson

See all 3 publications and co-authors

See who Dr. Millenson researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Millenson works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael M. Millenson has worked on 1 clinical trial

Dmand AI links Dr. Millenson to 1 clinical trial. Open Payments lists research payments to Dr. Millenson that name 1 trial.

Investigators on the most trials with Dr. Millenson

Recent clinical trials with Dr. Millenson

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Michael M. Millenson received $3,333 in industry payments from 2016 to 2024

CMS Open Payments shows 14 general payments to Dr. Millenson from 9 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 60% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,124. It also lists 3 research payments totaling $887 from 2017 to 2018, naming 1 clinical trial.

General payments to Dr. Millenson by program year, 2016 to 2024

General payments to Dr. Millenson by kind, 2016 to 2024

$3.3Kin total
  • Consulting fees$2,00060%
  • Food and beverage$1,00630%
  • Travel and lodging$2688%
  • Education$602%

Companies that paid Dr. Millenson the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Millenson

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael M. Millenson graduated from Lewis Katz School of Medicine

Dr. Millenson graduated from Lewis Katz School of Medicine in 1984.

  1. Medical schoolLewis Katz School of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Michael M. Millenson accepts plans from 10 insurance carriers

Dr. Millenson is in network with 10 carriers, including Elevance, Highmark and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.

Plan types Dr. Millenson accepts, by number of carriers

  1. Medicare9
  2. PPO8
  3. HMO6
  4. EPO2
  5. POS2

Source: Dmand AI Insurance Network Data

Sources for Dr. Michael M. Millenson's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael M. Millenson

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael M. Millenson's NPI number?

Dr. Michael M. Millenson's NPI number is 1871514224. It was assigned on July 21, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael M. Millenson?

Dr. Michael M. Millenson is a medical oncologist in Summit, New Jersey. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Michael M. Millenson practice?

Dr. Millenson practices at 99 Beauvoir Avenue, Summit, NJ 07901. Dr. Millenson's primary practice is Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System. Dmand AI also links Dr. Millenson to 1 medical group.

What is Dr. Michael M. Millenson's office phone number?

The practice phone on file for Dr. Millenson is (908) 522-2000.

What is Dr. Michael M. Millenson's medical license number?

Dr. Millenson holds Pennsylvania license MD034861E, one of the licenses on file in 4 states.

Which states has Dr. Michael M. Millenson been licensed in?

Dmand AI has state licenses on file for Dr. Millenson in Pennsylvania (1985 to 2026), Maine (since 1988), New Jersey (1988 to 1991) and North Carolina (1987 to 1988).

Which hospitals is Dr. Michael M. Millenson affiliated with?

Dr. Millenson practices at Overlook Medical Center in Summit, New Jersey. Dr. Millenson is also affiliated with Fox Chase Cancer Center.

What medical group is Dr. Michael M. Millenson part of?

Dr. Millenson is linked to Abington Pulmonary & Critical Care Associates. Dmand AI links Dr. Millenson to 1 more medical group.

Does Dr. Michael M. Millenson accept Medicare?

Yes. CMS data shows Dr. Millenson billed Medicare for 294 services in 2024.

How many Medicare patients does Dr. Michael M. Millenson see?

CMS counts 173 Medicare patients who saw Dr. Millenson in 2024, with an average age of 76.

Show 9 more questionsShow fewer questions

Is Dr. Michael M. Millenson board certified?

Yes. Dr. Millenson is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Michael M. Millenson bill to Medicare?

In 2024, Dr. Millenson's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99213).

Where did Dr. Michael M. Millenson go to medical school?

Dr. Millenson graduated from Lewis Katz School of Medicine in 1984.

What drugs does Dr. Michael M. Millenson prescribe most?

In 2024 Medicare Part D data, Dr. Millenson's most prescribed drugs by claims were Hydroxyurea, Imbruvica and Eliquis.

Has Dr. Michael M. Millenson received payments from drug or device companies?

CMS Open Payments shows $3,333 in general payments to Dr. Millenson from 9 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Michael M. Millenson been practicing?

Dr. Millenson graduated from medical school in 1984, 42 years ago.

Does Dr. Michael M. Millenson do research?

Dmand AI links 3 publications to Dr. Millenson, published from 2014 to 2018. Dr. Millenson has worked on 1 clinical trial.

Who does Dr. Michael M. Millenson publish with?

Dr. Millenson's most frequent co-authors are Sikander Ailawadhi, MD (1 shared paper), Stephen M. Ansell, MD (1 shared paper) and Siddhartha Ganguly, MD (1 shared paper).

What insurance does Dr. Michael M. Millenson accept?

Dr. Millenson is in network with 10 carriers, including Elevance, Highmark and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in New Jersey by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)